ID

41598

Descrição

Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Study Conclusion, Status of treatment blind, PGx research withdrawal of consent, Pregnancy information) is to be filled out at the End of the Study.

Link

https://clinicaltrials.gov/ct2/show/NCT00784550

Palavras-chave

  1. 19/11/2020 19/11/2020 -
Titular dos direitos

GlaxoSmithKline

Transferido a

19 de novembro de 2020

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550

Study Conclusion, Status of treatment blind, PGx research withdrawal of consent, Pregnancy information

Administrative Data
Descrição

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject identification number
Descrição

Subject identification number

Tipo de dados

text

Alias
UMLS CUI [1]
C2348585
Date of visit/assessment
Descrição

Date of visit/assessment

Tipo de dados

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
Study Conclusion
Descrição

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008976
Date of subject completion or withdrawal
Descrição

Date of subject completion should be the date of the follow-up phone call. If follow-up phone call was not done, enter the last scheduled visit date or the Early Withdrawal date.

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1549507
UMLS CUI [2,1]
C0422727
UMLS CUI [2,2]
C0011008
Was the patient withdrawn from the study?
Descrição

withdrawn from study

Tipo de dados

text

Alias
UMLS CUI [1]
C0422727
Primary reason for withdrawal
Descrição

If the subject is non-compliant, record as protocol deviation for reason of withdrawal.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
If investigator discretion, specify
Descrição

Reason for withdrawal: investigator discretion, specify

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0008961
UMLS CUI [1,4]
C0022423
UMLS CUI [1,5]
C2348235
Q1
Descrição

[hidden]

Tipo de dados

text

Q2
Descrição

[hidden]

Tipo de dados

text

Status of treatment: Blind
Descrição

Status of treatment: Blind

Alias
UMLS CUI-1
C0749659
UMLS CUI-2
C2347038
Was the treatment blind broken during the study?
Descrição

If yes, complete Non-Serious Adverse Event, Serious Adverse Event and/or Investigational Product form as appropriate.

Tipo de dados

text

Alias
UMLS CUI [1]
C3897431
If yes, complete Date blind broken
Descrição

Time blind broken is optional.

Tipo de dados

partialDatetime

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0011008
If yes, complete Reason blind broken
Descrição

Reason blind broken

Tipo de dados

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0392360
If yes and Other reason, specify
Descrição

Other reason blind broken

Tipo de dados

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0205394
Pharmacogenetic Research Withdrawal of Consent
Descrição

Pharmacogenetic Research Withdrawal of Consent

Alias
UMLS CUI-1
C1707492
UMLS CUI-2
C2347500
UMLS CUI-3
C1948029
UMLS CUI-4
C0438730
Has the subject withdrawn consent for PGx research?
Descrição

Consent for pharmacogenetic research withdrawn

Tipo de dados

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2347500
If yes, provide date informed consent was withdrawn
Descrição

Date informed consent withdrawn

Tipo de dados

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2347500
UMLS CUI [1,3]
C0011008
Has a request been made for saliva sample destruction?
Descrição

Request for saliva sample destruction

Tipo de dados

text

Alias
UMLS CUI [1,1]
C1272683
UMLS CUI [1,2]
C1948029
UMLS CUI [1,3]
C0438730
If yes, check reason
Descrição

Reason for Request of Saliva Sample Destruction

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0566251
UMLS CUI [1,2]
C1272683
UMLS CUI [1,3]
C1948029
UMLS CUI [1,4]
C0438730
It other reason, specify
Descrição

Other reason for request of saliva sample destruction

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0566251
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C1272683
UMLS CUI [1,4]
C1948029
UMLS CUI [1,5]
C0438730
Pregnancy Information
Descrição

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did the subject become pregnant during the study?
Descrição

If Yes, complete the paper Pregnancy Notification form.

Tipo de dados

text

Alias
UMLS CUI [1]
C3828490
Signatures
Descrição

Signatures

Alias
UMLS CUI-1
C1519316
By my dated signature below, I, [First Name] [Last Name], verify that all case report form pages accurately display the results of the examinations, tests, evaluations, and treatments performed on this patient. Pursuant to section 11.199 of Title 21 of the Code of Federal Regulations, this is to certify that I intend that this electronic signature is to be the legally binding equivalent of my handwritten signature.
Descrição

CRB Electronic Signature Affidavit

Tipo de dados

text

Alias
UMLS CUI [1]
C2346576
Date of signature
Descrição

CRB Electronic Signature Affidavit Date

Tipo de dados

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Name of Investigator (CRB)
Descrição

[First Name] [Last Name]

Tipo de dados

text

Alias
UMLS CUI [1]
C2826892
By my dated signature below, I, [First Name] [Last Name], verify that all case report form pages accurately display the results of the examinations, tests, evaluations, and treatments noted within. Pursuant to section 11.199 of Title 21 of the Code of Federal Regulations, this is to certify that I intend that this electronic signature is to be the legally binding equivalent of my handwritten signature.
Descrição

CRF Electronic Signature Affidavit

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C1516308
Date of signature
Descrição

CRF Electronic Signature Affidavit Date

Tipo de dados

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C1516308
UMLS CUI [1,3]
C0011008
Name of Investigator (CRF)
Descrição

[First Name] [Last Name]

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2826892
UMLS CUI [1,2]
C1516308

Similar models

Study Conclusion, Status of treatment blind, PGx research withdrawal of consent, Pregnancy information

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject identification number
Item
Subject identification number
text
C2348585 (UMLS CUI [1])
Date of visit/assessment
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C0008976 (UMLS CUI [1,1])
C1549507 (UMLS CUI [1,2])
C0422727 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
Item
Was the patient withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Code List
Was the patient withdrawn from the study?
CL Item
No (N)
CL Item
Yes, complete primary reason for withdrawal (Y)
Item
Primary reason for withdrawal
integer
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
Primary reason for withdrawal
CL Item
Adverse Event (record details on the Non-Serious Adverse Events or Serious Adverse Events from as appropriate) (1)
CL Item
Lack of efficacy (2)
CL Item
Protocol deviation (3)
CL Item
Lost to follow-up (6)
CL Item
Investigator discretion, specify (Select this reason if none of the other primary reasons are appropriate) (7)
CL Item
Withdrew consent (8)
Reason for withdrawal: investigator discretion, specify
Item
If investigator discretion, specify
text
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
Item
Q1
text
Code List
Q1
CL Item
Yes (Y)
CL Item
No (N)
Item
Q2
text
Code List
Q2
CL Item
PF_SC_LOST (?)
CL Item
PF_SC_DEATH (?)
CL Item
PF_SC_SPONSORDECISION (?)
CL Item
PF_SC_PHYSICIANDECISION (?)
CL Item
PF_SC_PATIENTDECISION (?)
CL Item
PF_SC_AE (?)
CL Item
PF_SC_ALE (?)
CL Item
PF_SC_CRITERIA (?)
CL Item
PF_SC_OTHER (?)
Item Group
Status of treatment: Blind
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
Item
Was the treatment blind broken during the study?
text
C3897431 (UMLS CUI [1])
Code List
Was the treatment blind broken during the study?
CL Item
No (N)
CL Item
Yes, complete date and reason (Y)
Date blind broken
Item
If yes, complete Date blind broken
partialDatetime
C3897431 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
If yes, complete Reason blind broken
text
C3897431 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
If yes, complete Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other, specify (Z)
Other reason blind broken
Item
If yes and Other reason, specify
text
C3897431 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Item Group
Pharmacogenetic Research Withdrawal of Consent
C1707492 (UMLS CUI-1)
C2347500 (UMLS CUI-2)
C1948029 (UMLS CUI-3)
C0438730 (UMLS CUI-4)
Item
Has the subject withdrawn consent for PGx research?
text
C1707492 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
Code List
Has the subject withdrawn consent for PGx research?
CL Item
No (N)
CL Item
Yes, provide date (Y)
Date informed consent withdrawn
Item
If yes, provide date informed consent was withdrawn
date
C1707492 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
Has a request been made for saliva sample destruction?
text
C1272683 (UMLS CUI [1,1])
C1948029 (UMLS CUI [1,2])
C0438730 (UMLS CUI [1,3])
Code List
Has a request been made for saliva sample destruction?
CL Item
No (N)
CL Item
Yes, check reason (Y)
Item
If yes, check reason
text
C0566251 (UMLS CUI [1,1])
C1272683 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C0438730 (UMLS CUI [1,4])
CL Item
Subject withdrew consent for PGx (3)
CL Item
Other, specify (Z)
Other reason for request of saliva sample destruction
Item
It other reason, specify
text
C0566251 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C1948029 (UMLS CUI [1,4])
C0438730 (UMLS CUI [1,5])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Did the subject become pregnant during the study?
text
C3828490 (UMLS CUI [1])
Code List
Did the subject become pregnant during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item Group
Signatures
C1519316 (UMLS CUI-1)
CRB Electronic Signature Affidavit
Item
By my dated signature below, I, [First Name] [Last Name], verify that all case report form pages accurately display the results of the examinations, tests, evaluations, and treatments performed on this patient. Pursuant to section 11.199 of Title 21 of the Code of Federal Regulations, this is to certify that I intend that this electronic signature is to be the legally binding equivalent of my handwritten signature.
text
C2346576 (UMLS CUI [1])
CRB Electronic Signature Affidavit Date
Item
Date of signature
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Name of Investigator (CRB)
Item
Name of Investigator (CRB)
text
C2826892 (UMLS CUI [1])
CRF Electronic Signature Affidavit
Item
By my dated signature below, I, [First Name] [Last Name], verify that all case report form pages accurately display the results of the examinations, tests, evaluations, and treatments noted within. Pursuant to section 11.199 of Title 21 of the Code of Federal Regulations, this is to certify that I intend that this electronic signature is to be the legally binding equivalent of my handwritten signature.
text
C2346576 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])
CRF Electronic Signature Affidavit Date
Item
Date of signature
date
C2346576 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Name of Investigator (CRF)
Item
Name of Investigator (CRF)
text
C2826892 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial